Diamine Oxidase Deficiency and Histamine Intolerance: From Gut Health to Systemic Inflammation —An Integrative Clinical Perspective
- 1 Saint James School of Medicine, Park Ridge, IL, USA
- 2 Saint James School of Medicine, Park Ridge, IL, USA
Abstract
Background: Diamine oxidase (DAO) deficiency plays a pivotal role in histamine intolerance (HIT), a condition driven by impaired histamine degradation. HIT manifests through a spectrum of gastrointestinal, dermatologic, and neurologic symptoms often misdiagnosed as allergic or inflammatory disorders. Objective: This review synthesizes emerging literature on the mechanisms, diagnostic challenges, and therapeutic strategies related to DAO deficiency. Methods: Following PRISMA 2020 guidelines, a comprehensive search was conducted across PubMed, Scopus, and Web of Science (2018-2025). Studies examining DAO activity, genetic variants, microbiome interactions, and supplementation outcomes were included. Results: Genetic polymorphisms, nutrient deficiencies, intestinal inflammation, and pharmacologic inhibition emerged as major contributors to DAO dysfunction. Clinical interventions, particularly DAO supplementation and low-histamine diets, demonstrate consistent symptom relief across multiple studies. Conclusion: DAO deficiency bridges gut physiology, immune modulation, and systemic health. Integrative approaches incorporating nutrition, genetics, and microbiome science offer a pathway toward personalized management of HIT.
- Maintz, L. and Novak, N. (2020) Histamine Intolerance: The Current State of the Art. Clinical & Experimental Allergy , 50, 728-739.
- Jochum, C. (2024) Histamine Intolerance: Symptoms, Diagnosis, and Beyond. Nutrients , 16, Article 1219. https://doi.org/10.3390/nu16081219
- Tan, Z., Ou, Y., Cai, W., Zheng, Y., Li, H., Mao, Y., et al. (2022) Advances in the Clinical Application of Histamine and Diamine Oxidase (DAO) Activity: A Review. Catalysts , 13, Article 48. https://doi.org/10.3390/catal13010048
- Peña-García, J., et al. (2023) The Use of Diamine Oxidase as a Marker for Histamine Intolerance. Nutrients , 15, Article 2734.
- García-Martín, E., et al. (2023) Prevalence of Genetic Diamine Oxidase Deficiency in Female Fibromyalgia Patients. Nutrients , 15, Article 926.
- Fortes Marin, E., Carrera Marcolin, L., Martí Melero, L., Tintoré Gazulla, M. and Beltran Porres, M. (2025) The Prevalence of Single Nucleotide Polymorphisms of the AOC1 Gene Associated with Diamine Oxidase (DAO) Enzyme Deficiency in Healthy Newborns: A Prospective Population-Based Cohort Study. Genes , 16, Article 141. https://doi.org/10.3390/genes16020141
- Izquierdo-Carrasco, F., et al. (2024) Prevalence and Clinical Picture of AOC1 Gene Variants in a Real-World Population with Symptoms of Histamine Intolerance. Journal of Clinical Medicine , 13, Article 1659.
- Okutan, G., Perucho Alcalde, T., Ruiz Casares, E., Penadés, B.F., Sánchez Niño, G.M., Terrén Lora, A., et al. (2023) Cumulative Effect of AOC1 Gene Variants on Symptoms and Pathological Conditions in Adult Women with Fibromyalgia: A Pilot Study. Frontiers in Genetics , 14, Article 1180777. https://doi.org/10.3389/fgene.2023.1180777
- García-Martín, E., et al. (2018) Diamine Oxidase Supplement Reduces Headache in Episodic Migraine Patients with DAO Deficiency: A Randomized Double-Blind Trial. Cephalalgia , 38, 1776-1785.
- Navarro-Chica, C., et al. (2023) Exogenous Supplementation with DAO Enzyme in Women with Suspected Histamine Intolerance: A Randomized Double-Blind Crossover Study. Journal of Clinical Medicine , 12, Article 6449.
- Ochoa-Sánchez, R., et al. (2025) Study Protocol for a Prospective, Double-Blind Randomized Trial on Low-Histamine Diet and DAO Supplementation. Trials , 26, Article 94.
- Ferrer, M., et al. (2023) Evaluation of the Safety and Tolerability of Three Single Ascending Doses of Diamine Oxidase in Healthy Volunteers. Medical Sciences Forum , 5, Article 46.